Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Settings
ILMN [NASD]
Illumina Inc.
Index- P/E63.35 EPS (ttm)2.90 Insider Own1.20% Shs Outstand144.04M Perf Week-4.90%
Market Cap26.46B Forward P/E44.94 EPS next Y4.09 Insider Trans-26.05% Shs Float142.84M Perf Month-0.36%
Income430.00M PEG2.78 EPS next Q0.77 Inst Own95.10% Short Float1.92% Perf Quarter-8.91%
Sales1.98B P/S13.37 EPS this Y163.30% Inst Trans0.03% Short Ratio2.48 Perf Half Y-1.15%
Book/sh11.29 P/B16.27 EPS next Y19.43% ROA13.10% Target Price229.88 Perf Year31.49%
Cash/sh9.49 P/C19.36 EPS next 5Y22.81% ROE31.60% 52W Range128.38 - 213.33 Perf YTD-0.47%
Dividend- P/FCF64.79 EPS past 5Y34.90% ROI15.20% 52W High-13.88% Beta0.82
Dividend %- Quick Ratio2.60 Sales past 5Y22.80% Gross Margin70.50% 52W Low43.10% ATR5.81
Employees3700 Current Ratio2.90 Sales Q/Q28.00% Oper. Margin26.30% RSI (14)41.80 Volatility4.32% 2.71%
OptionableYes Debt/Eq0.80 EPS Q/Q130.00% Profit Margin21.70% Rel Volume1.52 Prev Close189.59
ShortableYes LT Debt/Eq0.61 EarningsApr 21 AMC Payout0.00% Avg Volume1.10M Price183.71
Recom1.90 SMA20-2.51% SMA50-4.51% SMA2000.55% Volume1,675,075 Change-3.10%
Apr-22-15Reiterated Mizuho Buy $220 → $230
Mar-10-15Initiated UBS Buy $240
Jan-28-15Reiterated Stifel Buy $215 → $235
Jan-28-15Reiterated Maxim Group Buy $236 → $255
Jan-07-15Initiated Barclays Equal Weight $210
Oct-27-14Reiterated Stifel Buy $200 → $215
Oct-21-14Reiterated ISI Group Neutral $175 → $180.50
Aug-12-14Initiated Stifel Buy $200
Aug-01-14Initiated Tigress Financial Buy
Jul-24-14Reiterated Mizuho Buy $200 → $220
Jul-17-14Reiterated Maxim Group Buy $205 → $220
Apr-23-14Upgrade Maxim Group Hold → Buy $205
Apr-23-14Reiterated Mizuho Buy $175 → $200
Apr-23-14Reiterated ISI Group Neutral $152.50 → $162.50
Feb-19-14Reiterated UBS Buy $152 → $202
Jan-29-14Reiterated Mizuho Buy $150 → $175
Jan-29-14Reiterated ISI Group Neutral $134.50 → $147
Jan-17-14Reiterated Mizuho Buy $135 → $150
Jan-14-14Reiterated Mizuho Buy $125 → $135
Dec-19-13Reiterated Mizuho Buy $100 → $125
Apr-23-15 10:30AM  3 Top Stocks to Buy That Delivered Great Earnings at 24/7 Wall St.
06:00AM  Intel-Edico partnership aims to break a medical logjam at Fortune
Apr-22-15 06:39PM  Cloud Health Launches Full Service Capacity of the Illumina HiSeq X Ten Sequencing System at noodls
01:35PM  Stocks Higher After Soft Start; Facebook Up Pre-Earnings at Investor's Business Daily
11:53AM  Stocks Mildly Higher; China Nods To Visa, MasterCard at Investor's Business Daily
10:38AM  Stocks Take A Quiet Step Back; McDonald's, Visa, Tesla Climb at Investor's Business Daily
10:15AM  Illumina (ILMN) Tops Q1 Earnings, Revenues; EPS View Up - Analyst Blog
07:58AM  Illumina (ILMN) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
Apr-21-15 06:44PM  Yum! Brands, Chipotle, United Rentals Lead Tuesday's After-Hours Movers
06:00PM  Amgen, Illumina Earnings Hot, Intuitive Surgical Not at Investor's Business Daily
05:00PM  Illumina Inc Earnings Call scheduled for 5:00 pm ET today
04:27PM  Illumina beats Street 1Q forecasts
04:19PM  Illumina Reports Strong Start to Fiscal Year 2015 at noodls
04:08PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Illumina Reports Strong Start to Fiscal Year 2015 Business Wire
02:40PM  Will Thermo Fisher's (TMO) Q1 Earnings Surprise Investors? - Analyst Blog
09:56AM  Stocks narrowly mixed amid earnings; Nasdaq leads gains at CNBC
08:08AM  Wall Street optimistic on bumper earnings day at CNBC
07:28AM  Startup Pledges To Cut Cost Of Breast Cancer Genetic Testing From $4000 To $249 at Forbes
07:07AM  Q1 2015 Illumina Inc Earnings Release - After Market Close
Apr-20-15 03:15PM  Billionaire Andreas Halvorsens New Healthcare Pick at Insider Monkey
09:01AM  Immune System Drugs Melt Tumors In New Study, Leading A Cancer Revolution at Forbes
Apr-17-15 01:40PM  Can Illumina (ILMN) Keep the Earnings Streak Alive in Q1? - Analyst Blog
Apr-15-15 08:54AM  Why Illumina (ILMN) Might Surprise This Earnings Season - Tale of the Tape
Apr-14-15 05:30PM  Douglas C. Lane's Top Three Stocks for Q1 2015: Delta, United Continental and Illumina
Apr-08-15 12:02PM  It Takes Two To Tango: Combine Diagnostics And Drugs For Precision Medicine at Forbes
Apr-07-15 06:32AM  Illumina to Announce First Quarter 2015 Financial Results on Tuesday, April 21, 2015 at noodls
06:30AM  Illumina to Announce First Quarter 2015 Financial Results on Tuesday, April 21, 2015 Business Wire
Apr-01-15 08:14PM  Fetal DNA tests prove highly accurate but experts warn of exceptions Reuters
Mar-31-15 09:24AM  Berry Genomics NextSeq CN500 Instrument and Non-Invasive Prenatal Testing Reagent Kit Receives Chinese FDA Premarket Clearance at noodls
09:19AM  Berry Genomics NextSeq CN500 Instrument and Non-Invasive Prenatal Testing Reagent Kit Receives Chinese FDA Premarket Clearance Business Wire
Mar-27-15 09:30AM  The Zacks Analyst Blog Highlights: Methode Electronics, Newmont Mining, Valero Energy and Quest Diagnostics - Press Releases
09:30AM  The Zacks Analyst Blog Highlights: Horizon Pharma, NewLink Genetic and llumina - Press Releases
Mar-26-15 03:35PM  3 Biotech Stocks Bucking Short Interest Trends
02:55PM  The March Madness 'Sweet 16' of Stocks - Analyst Blog
02:12PM  Biotech Battering Renews Bubble Debate Over Sector's Pricey Stocks at Forbes
10:21AM  Biotech Crash -- How Long Will It Last? at Forbes
Mar-25-15 07:22PM  3 Excellent Biotech Stocks to Buy on the Dip - Stocks in the News
Mar-23-15 05:45PM  Health Care REIT Stocks Find Investors' Favor at Investor's Business Daily
10:03AM  Illumina Launches the NeoPrep Library Prep System at noodls
09:35AM  Illumina Names Albiogen as Eastern Europe Distributor at noodls
09:35AM  Illumina Launches TruSight HLA Solution at noodls
09:35AM  Illumina Files Patent Infringement Suit in the United Kingdom Against Premaitha Health plc for Infringement of NIPT Patents at noodls
09:35AM  Illumina Announces Strategic Collaboration with Merck Serono to Expand Companion Diagnostics for Oncology at noodls
09:35AM  Illumina Accelerator Secures $40 Million Boost Capital to Back New Graduates at noodls
09:30AM  The Zacks Analyst Blog Highlights: Natus Medical, Mead Johnson Nutrition, Amedisys, Quest Diagnostics and Illumina - Press Releases
Mar-20-15 06:05PM  Illumina (ILMN) Files NIPT Patent Infringement Suit in UK - Analyst Blog
03:18PM  International Day of Happiness: Stocks to Make You Smile - Analyst Blog
Mar-18-15 09:03AM  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer at noodls
08:31AM  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer PR Newswire
Mar-17-15 08:03AM  Billionaire Stan Druckenmillers Long-Term Picks at Insider Monkey
Mar-16-15 10:22AM  Analyzing Viking Global Investors Positions in 4Q14
04:05AM  Illumina Files Patent Infringement Suit in the United Kingdom Against Premaitha Health plc for Infringement of NIPT Patents Business Wire
Mar-13-15 04:00PM  Is Illumina (ILMN) Worth Adding to Your Portfolio Now? - Analyst Blog
Mar-12-15 06:11PM  Illumina Partners Merck KGaA to Develop Precision Medicine - Analyst Blog
Mar-10-15 09:00AM  Illumina Announces Strategic Collaboration with Merck Serono to Expand Companion Diagnostics for Oncology Business Wire
Mar-04-15 06:30AM  Illumina Launches TruSight HLA Solution Business Wire
Mar-03-15 05:04PM  Is Illumina (ILMN) Worth Adding to Your Portfolio Now? - Analyst Blog
05:45AM  Illumina attracts vote of confidence
Feb-26-15 06:30AM  Illumina Accelerator Secures $40 Million Boost Capital to Back New Graduates Business Wire
Feb-25-15 08:00AM  10X Genomics Unwraps Its 'Toaster Oven' For Better DNA Sequencing at Forbes
Feb-24-15 11:19PM  Thermo Fisher Scientific, Ingersoll-Rand plc: Billionaires Are Piling Into These 5 Capital Goods Stocks at Insider Monkey
06:51PM  Illumina Expands NGS Portfolio with NeoPrep Library System - Analyst Blog
01:04PM  ILLUMINA INC Financials
08:00AM  Five Things To Watch For At The Big Genomics Event at Forbes
Feb-23-15 06:30AM  Illumina Launches the NeoPrep Library Prep System Business Wire
Feb-20-15 07:07PM  10-K for Illumina, Inc. Company Spotlight
01:10PM  What 23andMe's FDA Approval Means For The Future Of Genomics at Forbes
01:03AM  Illumina, Inc., Walgreens Boots Alliance Inc, Valeant Pharmaceuticals Intl Inc: Billionaire Halvorsens Top 3 Picks at Insider Monkey
Feb-19-15 10:15PM  In Big Shift, FDA Plans To Let 23andMe Market Genetic Tests To Consumers at Forbes
Feb-18-15 06:30AM  Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference Business Wire
06:05AM  ILLUMINA INC Files SEC form 10-K, Annual Report EDGAR Online
Feb-16-15 07:15PM  Billionaire Stanley Druckenmillers Top 5 Picks Include Biogen Idec Inc (BIIB), Target Corporation (TGT), Home Depot Inc (HD) at Insider Monkey
Feb-13-15 05:08PM  Sony Betting Streaming Video Puts Its Comeback Into Focus at Investor's Business Daily
Feb-05-15 12:10PM  TrialReach Raises $13.5M Series B Led by Smedvig Capital PR Newswire
Feb-03-15 09:37AM  Illumina (ILMN) Stock Declines Today Despite Price Target Increase at TheStreet
08:35AM  Obama's New Healthcare Proposal: A Precise Vision Or A Political Football at Forbes
Feb-02-15 04:07PM  ILLUMINA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
09:05AM  Why Illuminas outlook is so bright Market Realist
Jan-31-15 11:24AM  First Hand Account: The White House Precision Medicine Announcement at Forbes
Jan-30-15 06:39PM  Many Leading Stocks Stumble But Biogen, Harman Soar at Investor's Business Daily
03:05PM  Illuminas results beat analysts estimates Market Realist
12:15PM  Obama unveils precision medicine initiative CNBC
10:47AM  Viking Global Investors reduces its position in Illumina Market Realist
08:44AM  UK to launch 100,000 genomes project as Obama backs DNA drive Reuters
07:05AM  Reinventing pharma's next big frontier: Pro CNBC
07:03AM  White House targets precision medicine CNBC
06:00AM  Obama's $215 Million DNA Sequencing Project Is A Great Idea at Forbes
Jan-29-15 06:03PM  Top Earnings News: Illumina Back In Base Despite Beat at Investor's Business Daily
Jan-28-15 05:31PM  How To Invest: Use Weekly Stock Charts Like A Pro at Investor's Business Daily
04:46PM  Wednesday's Market Recap Yahoo Finance Contributors
04:21PM  Stocks Sell Off Into Close; Illumina, Yahoo Reverse Lower at Investor's Business Daily
03:00PM  Stock Indexes Turn Mixed; Apple Stays Strong at Investor's Business Daily
02:35PM  Illumina Q4 Results Trigger Price Target Increases at Investor's Business Daily
01:32PM  Nasdaq Recovers After Reversal; Apple Shines Brightly at Investor's Business Daily
09:30AM  Illumina Tops Q4 Earnings on Solid Revenues, Margin Growth - Analyst Blog Zacks
08:35AM  Why the Earnings Streak Will Continue for Illumina (ILMN) - Tale of the Tape Zacks
07:36AM  Illumina (ILMN) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
01:00AM  Obama's 'precision medicine' plan to boost research, but faces hurdles Reuters
Jan-27-15 06:47PM  Illumina beats on huge EPS rise Investor's Business Daily
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms consist of HiScan and iScan systems, as well as NextSeq 550 system that are array scanners for DNA and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis. It also offers various library preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping, noninvasive prenatal test, and whole-genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. It has a collaboration agreement with Merck Serono to develop a sequencing-based oncology diagnostic. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FLATLEY JAY TChief Executive OfficerApr 23Option Exercise33.8025,000844,875449,996Apr 27 05:54 PM
FLATLEY JAY TChief Executive OfficerApr 23Sale189.5725,0004,739,274424,996Apr 27 05:54 PM
WALT DAVID RDirectorApr 21Sale197.9510,0001,979,515787,427Apr 23 07:21 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficApr 15Sale189.023,751709,02139,308Apr 16 06:38 PM
Naclerio NicholasSr VP, Corporate DevelopmentApr 15Sale189.056,5901,245,81041,457Apr 16 06:33 PM
WALT DAVID RDirectorApr 14Sale188.172,000376,33662,960Apr 15 06:59 PM
WALT DAVID RDirectorApr 14Sale188.255,000941,247797,427Apr 15 06:59 PM
Stapley MarcSr VP & CFOApr 13Option Exercise36.302,40087,12022,098Apr 15 06:26 PM
Bianchi Paul LSr. VP, Human ResourcesApr 13Sale187.223,390634,67667,887Apr 15 06:00 PM
Stapley MarcSr VP & CFOApr 13Sale190.123,000570,37319,098Apr 15 06:26 PM
Bouchard MichelChief Accounting OfficerApr 13Sale188.611,400264,05420,608Apr 15 07:11 PM
FLATLEY JAY TChief Executive OfficerApr 09Option Exercise33.8025,000844,875449,996Apr 13 07:02 PM
FLATLEY JAY TChief Executive OfficerApr 09Sale184.5525,0004,613,815424,996Apr 13 07:02 PM
BRADBURY DANIELDirectorApr 08Option Exercise75.661,700128,62214,166Apr 10 06:55 PM
BRADBURY DANIELDirectorApr 08Sale185.321,700315,04212,466Apr 10 06:55 PM
WALT DAVID RDirectorApr 07Sale184.285,000921,404802,427Apr 08 09:16 PM
WHITFIELD ROY ADirectorApr 06Option Exercise19.614,60090,20616,338Apr 08 07:40 PM
WHITFIELD ROY ADirectorApr 06Sale181.324,600834,07211,738Apr 08 07:40 PM
WALT DAVID RDirectorMar 31Sale186.005,000930,001807,427Apr 02 07:15 PM
WALT DAVID RDirectorMar 31Sale185.982,000371,95264,960Apr 02 07:15 PM
Dadswell CharlesSr VP & General CounselMar 27Sale184.629918,27742,690Mar 31 05:51 PM
FLATLEY JAY TChief Executive OfficerMar 26Option Exercise33.8025,000844,875449,996Mar 30 08:23 PM
FLATLEY JAY TChief Executive OfficerMar 26Sale181.3425,0004,533,467424,996Mar 30 08:23 PM
WALT DAVID RDirectorMar 24Sale192.165,000960,791812,427Mar 26 08:19 PM
BOWMAN A BLAINEDirectorMar 17Option Exercise39.143,000117,42015,722Mar 19 08:58 PM
BOWMAN A BLAINEDirectorMar 17Sale192.303,000576,90812,722Mar 19 08:58 PM
WALT DAVID RDirectorMar 17Sale192.575,000962,836817,427Mar 19 07:52 PM
WALT DAVID RDirectorMar 17Sale192.602,000385,19666,960Mar 19 07:52 PM
MOELLER GERALDDirectorMar 16Option Exercise75.662,700204,28220,244Mar 18 08:46 PM
BRADBURY DANIELDirectorMar 16Option Exercise75.661,700128,62214,166Mar 18 08:47 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMar 16Sale191.595,001958,16243,059Mar 18 08:47 PM
MOELLER GERALDDirectorMar 16Sale193.362,700522,07317,544Mar 18 08:46 PM
Naclerio NicholasSr VP, Corporate DevelopmentMar 16Sale193.946,5901,278,05748,047Mar 18 08:46 PM
BRADBURY DANIELDirectorMar 16Sale194.111,700329,99412,466Mar 18 08:47 PM
Bianchi Paul LSr. VP, Human ResourcesMar 13Sale186.673,390632,81171,277Mar 16 06:21 PM
Stapley MarcSr VP & CFOMar 12Option Exercise36.302,40087,12023,012Mar 13 07:36 PM
FLATLEY JAY TChief Executive OfficerMar 12Option Exercise33.8025,000844,875452,850Mar 16 06:46 PM
Bouchard MichelChief Accounting OfficerMar 12Sale189.951,752332,79222,008Mar 31 09:40 PM
Stapley MarcSr VP & CFOMar 12Sale189.013,314626,38819,698Mar 13 07:36 PM
FLATLEY JAY TChief Executive OfficerMar 12Sale189.4525,0004,736,126427,850Mar 16 06:46 PM
EPSTEIN ROBERT SDirectorMar 10Option Exercise51.172,000102,34010,042Mar 11 07:46 PM
EPSTEIN ROBERT SDirectorMar 10Sale191.753,000575,2507,042Mar 11 07:46 PM
Klausner RichardSr VP, Chief Medical OfficerMar 10Sale191.751,186227,41624,948Mar 11 07:46 PM
WALT DAVID RDirectorMar 10Sale192.385,000961,908822,427Mar 12 05:55 PM
WHITFIELD ROY ADirectorMar 05Option Exercise19.614,60090,20616,338Mar 09 08:32 PM
WHITFIELD ROY ADirectorMar 05Sale194.684,600895,50811,738Mar 09 08:32 PM
WALT DAVID RDirectorMar 03Sale193.752,000387,49568,960Mar 05 08:30 PM
WALT DAVID RDirectorMar 03Sale193.675,000968,361827,427Mar 05 08:30 PM
FLATLEY JAY TChief Executive OfficerFeb 26Option Exercise33.8025,000844,875452,850Feb 27 06:53 PM
FLATLEY JAY TChief Executive OfficerFeb 26Sale195.7325,0004,893,227427,850Feb 27 06:53 PM
WALT DAVID RDirectorFeb 24Sale199.519,5031,895,975832,427Feb 26 07:57 PM
Bianchi Paul LSr VP Human ResourcesFeb 19Sale199.9916,9513,390,01274,667Feb 23 07:54 PM
WALT DAVID RDirectorFeb 17Sale197.985,000989,925841,930Feb 19 07:10 PM
WALT DAVID RDirectorFeb 17Sale198.102,000396,20070,960Feb 19 07:10 PM
FLATLEY JAY TChief Executive OfficerFeb 12Option Exercise22.7925,000569,775377,241Feb 13 07:38 PM
FLATLEY JAY TChief Executive OfficerFeb 12Sale194.6425,0004,865,990357,241Feb 13 07:38 PM
WALT DAVID RDirectorFeb 10Sale193.625,000968,090846,930Feb 12 07:45 PM
WALT DAVID RDirectorFeb 03Sale190.885,000954,381851,930Feb 05 08:14 PM
WALT DAVID RDirectorFeb 03Sale190.922,000381,83772,960Feb 05 08:14 PM
EASTHAM KARINDirectorFeb 02Option Exercise43.9210,000439,18516,226Feb 03 08:37 PM
Bouchard MichelVP, Finance & Chief AccountingFeb 02Option Exercise69.3463243,82325,452Feb 02 09:26 PM
Naclerio NicholasSr VP & General ManagerFeb 02Option Exercise69.3411,250780,07534,268Feb 02 09:28 PM
EASTHAM KARINDirectorFeb 02Sale192.7710,0001,927,7089,726Feb 03 08:37 PM
Bianchi Paul LSr VP, Human ResourcesFeb 02Sale195.371,035202,20857,715Feb 02 09:26 PM
Bouchard MichelVP, Finance & Chief AccountingFeb 02Sale195.37632123,47424,820Feb 02 09:26 PM
Naclerio NicholasSr VP & General ManagerFeb 02Sale193.0211,2502,171,45823,018Feb 02 09:28 PM
Naclerio NicholasSr VP & General ManagerJan 30Option Exercise43.374,000173,48028,129Feb 02 09:28 PM
Naclerio NicholasSr VP & General ManagerJan 30Sale198.174,000792,69124,129Feb 02 09:28 PM
WALT DAVID RDirectorJan 27Option Exercise6.234,00024,900860,930Jan 29 06:34 PM
WALT DAVID RDirectorJan 27Sale201.764,000807,047856,930Jan 29 06:34 PM
Dadswell CharlesSr VP & General CounselJan 27Sale198.9022444,55443,036Jan 28 07:00 PM
FLATLEY JAY TChief Executive OfficerJan 22Option Exercise20.0425,000501,000390,478Jan 23 08:06 PM
FLATLEY JAY TChief Executive OfficerJan 22Sale188.4825,0004,712,079365,478Jan 23 08:06 PM
WALT DAVID RDirectorJan 20Option Exercise6.234,00024,900860,930Jan 22 05:54 PM
RASTETTER WILLIAM HDirectorJan 20Option Exercise6.2316,00099,60021,953Jan 22 03:19 PM
WALT DAVID RDirectorJan 20Sale194.432,000388,85474,960Jan 22 05:54 PM
WALT DAVID RDirectorJan 20Sale194.364,000777,420856,930Jan 22 05:54 PM
RASTETTER WILLIAM HDirectorJan 20Sale188.9916,0003,023,8945,953Jan 22 03:19 PM
WALT DAVID RDirectorJan 13Option Exercise6.234,00024,900860,930Jan 15 07:42 PM
WALT DAVID RDirectorJan 13Sale187.064,000748,250856,930Jan 15 07:42 PM
FLATLEY JAY TChief Executive OfficerJan 08Option Exercise20.0425,000501,000390,478Jan 09 07:30 PM
FLATLEY JAY TChief Executive OfficerJan 08Sale197.6225,0004,940,542365,478Jan 09 07:30 PM
WALT DAVID RDirectorJan 06Option Exercise6.234,00024,900860,930Jan 08 06:28 PM
WALT DAVID RDirectorJan 06Sale188.522,000377,03176,960Jan 08 06:28 PM
WALT DAVID RDirectorJan 06Sale188.564,000754,240856,930Jan 08 06:28 PM
Bouchard MichelVP, Finance & Chief AccountingJan 02Option Exercise69.3463143,75426,665Jan 05 07:35 PM
EASTHAM KARINDirectorJan 02Option Exercise36.2910,000362,90019,726Jan 05 07:35 PM
Bouchard MichelVP, Finance & Chief AccountingJan 02Sale186.17631117,47326,034Jan 05 07:35 PM
EASTHAM KARINDirectorJan 02Sale185.6310,0001,856,2519,726Jan 05 07:35 PM
WALT DAVID RDirectorDec 30Sale186.955,000934,741859,630Dec 30 06:28 PM
MOELLER GERALDDirectorDec 29Option Exercise42.818,000342,48025,457Dec 29 07:39 PM
Dadswell CharlesSr VP & General CounselDec 29Sale188.2014627,47743,260Dec 29 07:39 PM
MOELLER GERALDDirectorDec 29Sale187.058,0001,496,43917,457Dec 29 07:39 PM
FLATLEY JAY TChief Executive OfficerDec 26Option Exercise20.0425,000501,000390,478Dec 29 07:39 PM
FLATLEY JAY TChief Executive OfficerDec 26Sale186.7125,0004,667,817365,478Dec 29 07:39 PM
WALT DAVID RDirectorDec 23Sale184.565,000922,819864,830Dec 24 01:36 PM
WALT DAVID RDirectorDec 23Sale184.502,000369,00878,960Dec 24 01:36 PM
WALT DAVID RDirectorDec 16Sale178.355,000891,768869,630Dec 17 09:41 PM
Stapley MarcSr VP & CFODec 15Option Exercise36.301,42251,61925,706Dec 17 01:54 PM
Stapley MarcSr VP & CFODec 15Sale181.091,422257,50424,284Dec 17 01:54 PM